JP Morgan Maintains Neutral on Zimmer Biomet Holdings, Raises Price Target to $120
Benzinga Newsdesk 5 hours ago
Analyst RatingsNewsPrice Target
JP Morgan analyst Robbie Marcus maintains Zimmer Biomet Holdings (NYSE:ZBH) with a Neutral and raises the price target from $117 to $120.
JP Morgan analyst Robbie Marcus maintains Zimmer Biomet Holdings (NYSE:ZBH) with a Neutral and raises the price target from $117 to $120.